List of Excipients in API meloxicam, rizatriptan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing meloxicam, rizatriptan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc | SYMBRAVO | meloxicam, rizatriptan | 81968-020 | BETADEX SULFOBUTYL ETHER SODIUM | 2028-01-30 |
| Axsome Therapeutics Inc | SYMBRAVO | meloxicam, rizatriptan | 81968-020 | CELLULOSE, MICROCRYSTALLINE | 2028-01-30 |
| Axsome Therapeutics Inc | SYMBRAVO | meloxicam, rizatriptan | 81968-020 | CROSPOVIDONE | 2028-01-30 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for meloxicam, rizatriptan
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
meloxicam, rizatriptan drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
meloxicam, rizatriptan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
meloxicam, rizatriptan drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
meloxicam, rizatriptan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
meloxicam, rizatriptan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
meloxicam, rizatriptan drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
meloxicam, rizatriptan drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
meloxicam, rizatriptan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
meloxicam, rizatriptan drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
meloxicam, rizatriptan drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
meloxicam, rizatriptan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
meloxicam, rizatriptan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Axsome Therapeutics Inc | meloxicam, rizatriptan | 81968-020 |
| >Company | >Ingredient | >NDC |
meloxicam, rizatriptan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch